Kalager & Partners
3 January 2026

US Small-Cap Quality 50: Risk Analysis

Lower volatility than small-cap value, positive full-sample alpha, and sharp post-crisis rebounds across two decades of U.S. markets.

13.6%
Ann. Return (2006–2026)
26.8%
Ann. Volatility
0.55
Sharpe Ratio (vs 0.55 Mkt)
0.83 / +5.2%
FF5 R² / Ann. Alpha

Summary

The quality screen selects 50 U.S. non-financial small-cap stocks with a market capitalisation of at least $50 million, ranked by return on equity (ROE) from point-in-time SEC filings. Each stock starts at an equal 2% weight at the semi-annual March and September rebalances.

From March 2006 to September 2026, annualised returns rose from 8.4% in 2006–2015 to 18.8% in 2016–2026, averaging 13.6% a year overall with 26.8% annualised volatility (a 0.55 Sharpe ratio, matching the Fama–French Market benchmark while outperforming its 11.2% CAGR).

The Fama–French five-factor model explained 83% of daily return variation (R² = 0.83) over the full 20-year window and identified +5.2% annualised alpha (p = 0.037).


1. Performance Through Stress: 2006–2015 (GFC & Recovery)

The 2008–2009 credit freeze tested whether high-ROE small-caps held up better than deep-value peers. Switch the interactive chart above to 2006–2015 and toggle Drawdown to compare the path.

  • Drawdown: The portfolio fell 62.4% from July 2007 to March 2009, versus 54.6% for the market benchmark (and milder than small-cap value’s -67.4%).
  • Recovery: NAV regained its prior peak in 11.8 months from the March 2009 trough, versus 35.7 months for the market benchmark.
  • Factors: Market (+1.05) and size (+0.81) drove most of the variance (R² = 0.90), with near-zero value exposure (-0.08).
  • Returns: The portfolio returned 8.4% a year with 26.7% annualised volatility (Sharpe 0.40 vs. 0.38 market) and lost money in 7 of 20 half-year periods.

2. Modern Market Regime: 2016–2026 (COVID-19 & Rate Cycles)

In the second decade, small-cap quality compounded substantially faster while keeping volatility steady at 26.9%.

  • Drawdown: The portfolio fell 46.0% into the March 2020 trough, versus 34.2% for the market benchmark.
  • Recovery: Portfolio NAV regained its prior high in 2.6 months, outpacing the market’s 4.4-month recovery.
  • Factors: Market (+0.98) and size (+0.96) remained the primary exposures (R² = 0.77), with +7.6% annualised alpha (p = 0.053).
  • Returns: The portfolio returned 18.8% a year with 26.9% annualised volatility (Sharpe 0.69 vs. 0.74 market), posting losses in 7 of 22 half-year periods.

Full-Sample & Regime Summary

Metric Full Sample (2006–2026) 2006–2015 Regime 2016–2026 Regime
Annualised Return 13.6% (11.2% Mkt) 8.4% (7.2% Mkt) 18.8% (15.2% Mkt)
Annualised Volatility 26.8% (19.6% Mkt) 26.7% (21.0% Mkt) 26.9% (18.3% Mkt)
Sharpe Ratio 0.55 (0.55 Mkt) 0.40 (0.38 Mkt) 0.69 (0.74 Mkt)
Max Drawdown -62.4% (-54.6% Mkt) -62.4% (-54.6% Mkt) -46.0% (-34.2% Mkt)
Post-Trough Recovery 11.8 months (35.7m Mkt) 11.8 months 2.6 months (4.4m Mkt)
Negative Half-Year Periods 14 / 42 7 / 20 7 / 22
Fama–French 5-Factor R² 0.83 0.90 0.77
FF5 Annualised Alpha +5.2% (p = 0.037) +2.2% (p = 0.428) +7.6% (p = 0.053)

Conclusion

Small-cap quality dampened volatility by roughly four percentage points relative to US Small-Cap Value 50 while still generating statistically significant positive alpha over the 20-year window. As seen in US Mid-Cap Quality 50, that profitability edge eroded sharply once the universe floor moved up to $500 million.